Emtricitabine; Tenofovir Alafenamide Fumarate Patent Expiration
Emtricitabine; Tenofovir Alafenamide Fumarate is Used for managing and treating HIV infection. It was first introduced by Gilead Sciences Inc
Emtricitabine; Tenofovir Alafenamide Fumarate Patents
Given below is the list of patents protecting Emtricitabine; Tenofovir Alafenamide Fumarate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Descovy |
US8754065 (Pediatric) | Tenofovir alafenamide hemifumarate | Feb 15, 2033 | Gilead Sciences Inc |
| Descovy |
US9296769 (Pediatric) | Tenofovir alafenamide hemifumarate | Feb 15, 2033 | Gilead Sciences Inc |
| Descovy | US8754065 | Tenofovir alafenamide hemifumarate | Aug 15, 2032 | Gilead Sciences Inc |
| Descovy | US9296769 | Tenofovir alafenamide hemifumarate | Aug 15, 2032 | Gilead Sciences Inc |
| Descovy |
US7390791 (Pediatric) | Prodrugs of phosphonate nucleotide analogues | Jul 07, 2025 | Gilead Sciences Inc |
| Descovy | US7390791 | Prodrugs of phosphonate nucleotide analogues |
Jan 07, 2025
(Expired) | Gilead Sciences Inc |
| Descovy | US7803788 | Prodrugs of phosphonate nucoleotide analogues |
Feb 02, 2022
(Expired) | Gilead Sciences Inc |
| Descovy |
US6703396 (Pediatric) | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
Sep 09, 2021
(Expired) | Gilead Sciences Inc |
| Descovy |
US6642245 (Pediatric) | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
May 04, 2021
(Expired) | Gilead Sciences Inc |
| Descovy | US6703396 | Method of resolution and antiviral activity of 1,3-oxathiolane nuclesoside enantiomers |
Mar 09, 2021
(Expired) | Gilead Sciences Inc |
| Descovy | US6642245 | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
Nov 04, 2020
(Expired) | Gilead Sciences Inc |
| Descovy |
US5914331 (Pediatric) | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
Jan 02, 2018
(Expired) | Gilead Sciences Inc |
| Descovy | US5914331 | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
Jul 02, 2017
(Expired) | Gilead Sciences Inc |
| Descovy |
US5814639 (Pediatric) | Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds |
Mar 29, 2016
(Expired) | Gilead Sciences Inc |
| Descovy | US5814639 | Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds |
Sep 29, 2015
(Expired) | Gilead Sciences Inc |
Emtricitabine; Tenofovir Alafenamide Fumarate's Family Patents
Explore Our Curated Drug Screens
Emtricitabine; Tenofovir Alafenamide Fumarate Generic API Manufacturers
Several generic applications have been filed for Emtricitabine; Tenofovir Alafenamide Fumarate. The first generic version for Emtricitabine; Tenofovir Alafenamide Fumarate was by Apotex Inc and was approved on May 17, 2024. And the latest generic version is by Lupin Ltd and was approved on Dec 13, 2024.
Given below is the list of companies who have filed for Emtricitabine; Tenofovir Alafenamide Fumarate generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX
Apotex Inc has filed for 2 different strengths of generic version for Emtricitabine; Tenofovir Alafenamide Fumarate. All of these versions come by the name EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 120MG; EQ 15MG BASE | tablet | Discontinued | ORAL | N/A | May 17, 2024 |
| 200MG; EQ 25MG BASE | tablet | Discontinued | ORAL | N/A | May 17, 2024 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
2. LUPIN LTD
Lupin Ltd has filed for 1 generic for Emtricitabine; Tenofovir Alafenamide Fumarate. This 200mg;eq 25mg base version comes by the name EMTRICITABINE AND TENOFOVIR ALAFENAMIDE FUMARATE. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 200MG; EQ 25MG BASE | tablet | Prescription | ORAL | AB | Dec 13, 2024 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||